Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01592448 · ClinicalTrials.gov registry record
Investigation of Efficacy of Improved Acetaminophen Labeling
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 662
- Enrollment target
NCT01592448: Completed study, sponsored by Northwestern University.
NCT01592448 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 662 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01592448 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 662 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate, through brief, one-on-one cognitive interviews, the efficacy of 'enhanced' acetaminophen messages and icons in improving consumer understanding and use of prescription (Rx) and non-prescription (over-the-counter, OTC) acetaminophen containing products compared to the current standard.
Primary Outcome
Functional understanding (via teachback and demonstration) of acetaminophen label information (OTC \& Rx), including 1) active ingredient, 2) maximum daily dose, and 3) risks associated with misuse.
Interventions
- BEHAVIORAL Active Ingredient Icon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 662 participants |
| Start Date | 2012-10 |
| Est. Completion | 2013-03 |
What the finished NCT01592448 record still lists
NCT01592448 is an observational study that tracks outcomes without assigning an intervention. The registered 662 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Active Ingredient Icon is the first listed.
NCT01592448 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01592448 about?
NCT01592448 is a clinical study titled "Investigation of Efficacy of Improved Acetaminophen Labeling". The purpose of this study is to evaluate, through brief, one-on-one cognitive interviews, the efficacy of 'enhanced' acetaminophen messages and icons in improving consumer understanding and use of prescription (Rx) and non-prescription (over-the-counter, OTC) acetaminophen containing products compar...
What is the current status of trial NCT01592448?
This trial is currently completed. The enrollment target is 662 participants. The study started on 2012-10. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01592448?
The interventions under investigation include: Active Ingredient Icon (BEHAVIORAL).
Who is sponsoring clinical trial NCT01592448?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05254743 · 662 participants · Phase 3
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- NCT07164443 · 663 participants · Phase 3
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- NCT06607341 · 664 participants · NA
Community Engagement Alliance Against Disparities
- NCT01185132 · 660 participants · Phase 3
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia